Apellis Pharmaceuticals Inc (APLS)
33.18
+0.04
(+0.11%)
USD |
NASDAQ |
Dec 20, 16:00
33.18
0.00 (0.00%)
After-Hours: 20:00
Apellis Pharmaceuticals Shareholders Equity (Quarterly): 237.12M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biogen Inc | 16.36B |
| Biomarin Pharmaceutical Inc | 5.413B |
| Ionis Pharmaceuticals Inc | 662.47M |
| QuidelOrtho Corp | 3.187B |
| Moderna Inc | 11.93B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 901.87M |
| Total Liabilities (Quarterly) | 664.74M |
| Debt to Equity Ratio | 1.907 |
| Current Ratio | 4.36 |
| Net Debt Paydown Yield | -2.04% |